Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 20,470 shares at $48.02 ($983K) on 2025-09-29, disclosed to the SEC on 2025-09-30.
Scheduled sale ($983k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.02 | 10,235 | $491K | 50.0% |
| 2 | $48.02 | 10,235 | $491K | 50.0% |
| Total | $48.02 avg | 20,470 | $983K | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |